According to Hitachi, an F31 is "A compact system with outstanding performance, for a wide range of applications." ​

The best happy hour conversations start and end with UPF1. 

Hosted at Mt. Snow, Vermont, the 2nd Gordon Research Conference on ALS and related motor neuron diseases (July 21-26, 2019) attracted investigators from around the world. Kate gave an invited talk at the Gordon Research Seminar that preceded the conference, Nico gave a short talk based on his poster, Mike and Ahmed both presented posters, and Sami led the session on RNA metabolism. Not a bad showing! 

LATE (limbic predominant age-associated TDP43 encephalopathy) is a recently described condition that may be responsible for memory decline in the oldest old (>85 years). While the prevalence of Alzheimer's decreases in this demographic, LATE continues to rise. But because LATE looks clinically indistinguishable from Alzheimer's, many people are inadvertently diagnosed with Alzheimer's, treated as if they have Alzheimer's, and are enrolled in studies for new treatments in Alzheimer's. While we have known that TDP43 is involved in ALS, frontotemporal dementia and perhaps Alzheimer's, this is one of the first indications that TDP43 may be primarily responsible for a disorder of memory in a growing fraction of the population. You can read about LATE and its implications below.

All dressed up... and places to go! ​Congrats Brittany!

Nice moves, man.

Congratulations to Kate, Nate and Roberto! In one of the fastest peer review processes ever, their manuscript on neuronal survival was recently accepted for publication in the Journal of Visualized Experiments. 

Congrats to Lisa, Ahmet and Nate! Their work on Ubiquilin-2 in ALS and FTD was recently accepted for publication at  Proceedings of the National Academy of Sciences, USA. This was a concerted effort that included many from Hank Paulson's group and Magda Ivanova's lab as well as our own.